Loading...
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with chronic HCV infection. A r...
Na minha lista:
| Udgivet i: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5041021/ https://ncbi.nlm.nih.gov/pubmed/27490575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines4030027 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|